Absolute levels of the novel anti-IL-17A antibody, secukinumab, in skin can be quantified by dermal open flow microperfusion (dOFM).

G Bruin; C Dragatin; Birgit Sadoghi; F Polus; C Calonder; C Froeliger; K Tiffner; Manfred Weiss; Julia Mader; Stefan Korsatko; M Ratzer; Thomas Pieber; C Loesche; Frank Michael Sinner

Absolute levels of the novel anti-IL-17A antibody, secukinumab, in skin can be quantified by dermal open flow microperfusion (dOFM).

G Bruin
, C Dragatin
, Birgit Sadoghi
, F Polus
, C Calonder
, C Froeliger
, K Tiffner
, Manfred Weiss
, Julia Mader
, Stefan Korsatko
, M Ratzer
, Thomas Pieber
, C Loesche
, Frank Michael Sinner

Publikation: Beitrag in Fachzeitschrift › Konferenzabstract

1 Quellenangabe (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Journal of Investigative Dermatology
Publikationsstatus	Veröffentlicht - 2013
Veranstaltung	IID 2013: International Investigative Dermatology Meeting - Edinburgh, Großbritannien/Vereinigtes Königreich Dauer: 8 Mai 2013 → 11 Mai 2013

Wissenschaftszweige

301 Medizinisch-theoretische Wissenschaften, Pharmazie
302 Klinische Medizin
305 Andere Humanmedizin, Gesundheitswissenschaften
107 Andere Naturwissenschaften

Andere Dateien und Links

Web of Science

Absolute levels of the novel anti-IL-17A antibody, secukinumab, in skin can be quantified by dermal open flow microperfusion (dOFM).
Bruin, G. (Autor*in), Dragatin, C. (Autor*in), Sadoghi, B. (Autor*in), Polus, F. (Autor*in), Calonder, C. (Autor*in), Froeliger, C. (Autor*in), Tiffner, K. (Autor*in), Weiss, M. (Autor*in), Mader, J. (Autor*in), Korsatko, S. (Autor*in), Ratzer, M. (Autor*in), Pieber, T. (Autor*in), Loesche, C. (Autor*in) & Sinner, F. M. (Autor*in)
2013
Aktivität: Vortrag oder Poster › Poster

Dieses zitieren

@article{1e91ce34fa9e4653a93f1c45c1601c45,

title = "Absolute levels of the novel anti-IL-17A antibody, secukinumab, in skin can be quantified by dermal open flow microperfusion (dOFM).",

author = "G Bruin and C Dragatin and Birgit Sadoghi and F Polus and C Calonder and C Froeliger and K Tiffner and Manfred Weiss and Julia Mader and Stefan Korsatko and M Ratzer and Thomas Pieber and C Loesche and Sinner, \{Frank Michael\}",

year = "2013",

language = "English",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

publisher = "Elsevier B.V.",

note = "IID 2013: International Investigative Dermatology Meeting ; Conference date: 08-05-2013 Through 11-05-2013",

}

TY - JOUR

T1 - Absolute levels of the novel anti-IL-17A antibody, secukinumab, in skin can be quantified by dermal open flow microperfusion (dOFM).

AU - Bruin, G

AU - Dragatin, C

AU - Sadoghi, Birgit

AU - Polus, F

AU - Calonder, C

AU - Froeliger, C

AU - Tiffner, K

AU - Weiss, Manfred

AU - Mader, Julia

AU - Korsatko, Stefan

AU - Ratzer, M

AU - Pieber, Thomas

AU - Loesche, C

AU - Sinner, Frank Michael

PY - 2013

Y1 - 2013

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000317698900307

M3 - Conference abstract

SN - 0022-202X

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

T2 - IID 2013: International Investigative Dermatology Meeting

Y2 - 8 May 2013 through 11 May 2013

ER -

Absolute levels of the novel anti-IL-17A antibody, secukinumab, in skin can be quantified by dermal open flow microperfusion (dOFM).

Wissenschaftszweige

Andere Dateien und Links

Aktivitäten

Absolute levels of the novel anti-IL-17A antibody, secukinumab, in skin can be quantified by dermal open flow microperfusion (dOFM).

Dieses zitieren